Jinwang Wei

1.0k total citations
21 papers, 783 citations indexed

About

Jinwang Wei is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jinwang Wei has authored 21 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jinwang Wei's work include Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Bone and Dental Protein Studies (4 papers). Jinwang Wei is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Bone and Dental Protein Studies (4 papers). Jinwang Wei collaborates with scholars based in China, United States and Canada. Jinwang Wei's co-authors include Lun–Xiu Qin, Qiongzhu Dong, Yuan‐Yuan Sheng, Xiaomei Gao, Hu‐Liang Jia, Ning Ren, Yan Zheng, Qing‐Hai Ye, Haijun Zhou and Qiao Peng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Jinwang Wei

21 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinwang Wei China 14 446 405 219 105 105 21 783
Yangfan Lv China 16 583 1.3× 359 0.9× 205 0.9× 87 0.8× 130 1.2× 31 892
So Mee Kwon South Korea 18 510 1.1× 337 0.8× 199 0.9× 143 1.4× 140 1.3× 29 892
Qiongyan Zhang China 16 634 1.4× 537 1.3× 256 1.2× 124 1.2× 158 1.5× 27 972
Ming Quan China 18 584 1.3× 264 0.7× 200 0.9× 79 0.8× 101 1.0× 37 799
Fumie Omotehara Japan 17 454 1.0× 197 0.5× 253 1.2× 99 0.9× 65 0.6× 32 769
David G. Mollevı́ Spain 15 332 0.7× 165 0.4× 432 2.0× 79 0.8× 114 1.1× 25 744
Hye Kyung Hong South Korea 20 432 1.0× 297 0.7× 442 2.0× 71 0.7× 118 1.1× 39 954
Xiao Feng China 15 580 1.3× 630 1.6× 149 0.7× 72 0.7× 68 0.6× 18 900
Jinxue Zhou China 16 326 0.7× 220 0.5× 271 1.2× 92 0.9× 94 0.9× 32 744

Countries citing papers authored by Jinwang Wei

Since Specialization
Citations

This map shows the geographic impact of Jinwang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinwang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinwang Wei more than expected).

Fields of papers citing papers by Jinwang Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinwang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinwang Wei. The network helps show where Jinwang Wei may publish in the future.

Co-authorship network of co-authors of Jinwang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jinwang Wei. A scholar is included among the top collaborators of Jinwang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinwang Wei. Jinwang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Cheng, Jinming Li, Guang Liu, et al.. (2024). Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer. Microbiome. 12(1). 274–274. 5 indexed citations
2.
Peng, Liang, Jinsheng Tao, Bo Wang, et al.. (2024). Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules. SHILAP Revista de lepidopterología. 5(8). e644–e644. 2 indexed citations
3.
Huo, Jiaying, Mei Li, Jinwang Wei, et al.. (2022). RNA-seq based elucidation of mechanism underlying the protective effect of Huangshui polysaccharide on intestinal barrier injury in Caco-2 cells. Food Research International. 162(Pt B). 112175–112175. 17 indexed citations
4.
Wang, Xue, Yunhua Xu, Ruiying Zhao, et al.. (2022). An open, observational, three-arm clinical study of 2–3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis. Frontiers in Immunology. 13. 938269–938269. 6 indexed citations
5.
Zhou, Chuang, Fei Xu, Jinwang Wei, et al.. (2021). Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing. Annals of Translational Medicine. 9(18). 1437–1437. 13 indexed citations
6.
Cai, Xiuyu, Meiling Deng, Zhiyong Li, et al.. (2020). Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma. Annals of Translational Medicine. 8(18). 1176–1176. 8 indexed citations
7.
Li, Jiaping, Wei Jiang, Jinwang Wei, et al.. (2020). Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors. Journal of Translational Medicine. 18(1). 293–293. 27 indexed citations
8.
Zang, Yuan‐Sheng, Chun Dai, Xiaoman Xu, et al.. (2019). Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer. Cancer Medicine. 8(10). 4699–4708. 48 indexed citations
9.
Wei, Jinwang, Yuan‐Yuan Sheng, Jianhua Li, et al.. (2019). Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma. Medical Science Monitor. 25. 2452–2478. 13 indexed citations
10.
Bai, Yuxian, Guan Wang, Jinwang Wei, et al.. (2019). Using Clinical Genomic Sequencing to Guide Personalized Cancer Therapy in China. Personalized Medicine. 16(4). 287–299. 3 indexed citations
11.
Gao, Xiaomei, Yuan‐Yuan Sheng, Jing Yang, et al.. (2018). Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 179–179. 48 indexed citations
12.
Zheng, Yan, Chuang Zhou, Xinxin Yu, et al.. (2018). Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of β-Catenin. Cell Death and Disease. 9(2). 179–179. 47 indexed citations
13.
Liu, Zhenhao, Baofeng Lian, Qiongzhu Dong, et al.. (2018). Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(6). 2360–2368. 53 indexed citations
14.
Yang, Jing, Yuan‐Yuan Sheng, Jinwang Wei, et al.. (2018). MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1. BioMed Research International. 2018. 1–10. 23 indexed citations
15.
Sheng, Yuan‐Yuan, Jinwang Wei, Yu Zhang, et al.. (2018). Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma. International Journal of Cancer. 144(10). 2440–2452. 21 indexed citations
16.
Dong, Qiongzhu, Xuchao Zhu, Chun Dai, et al.. (2016). Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin. Oncotarget. 7(11). 12997–13012. 61 indexed citations
17.
Wang, Zheng, Yuan‐Yuan Sheng, Xiaomei Gao, et al.. (2015). β-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma. Molecular and Clinical Oncology. 3(4). 936–940. 39 indexed citations
18.
Yang, Xin, Lei Liang, Xiaofei Zhang, et al.. (2013). MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology. 58(1). 158–170. 245 indexed citations
19.
Zhu, Haitao, Qiongzhu Dong, Yuan‐Yuan Sheng, et al.. (2012). MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection. PLoS ONE. 7(12). e52393–e52393. 48 indexed citations
20.
Ren, Ning, Jincai Wu, Qiongzhu Dong, et al.. (2011). Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma. Cancer Research. 71(9). 3278–3286. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangfan Lv Breakdown of academic impact, for papers by So Mee Kwon Breakdown of academic impact, for papers by Qiongyan Zhang Breakdown of academic impact, for papers by Ming Quan Breakdown of academic impact, for papers by Fumie Omotehara Breakdown of academic impact, for papers by David G. Mollevı́ Breakdown of academic impact, for papers by Hye Kyung Hong Breakdown of academic impact, for papers by Xiao Feng Breakdown of academic impact, for papers by Jinxue Zhou
Rankless by CCL
2026